Human anti-semaphorin 4D antibody
AssigneeVaccinex, Inc.
InventorsErnest S. Smith, Angelica Cornelison, Maria Scrivens, Mark Paris, Maurice Zauderer
Life of this patent
Estimating the term…
Abstract
Compositions and method are provided for treating diseases associated with semaphorin-4D (SEMA4D) pathology, including autoimmune diseases, inflammatory diseases, cancers, neuroinflammatory disorders and neurodegenerative diseases.
Claims27
A composition comprising an antibody or antigen-binding fragment thereof that specifically binds to semaphorin-4D (SEMA4D) comprising a heavy chain variable region (VH) and a light chain variable region (VL), wherein the VH comprises complementarity determining regions (HCDRs) HCDR1, HCDR2, and HCDR3 comprising amino acid sequences SEQ ID NO:
- 2, SEQ ID NO:
- 3, and SEQ ID NO:
- 4, respectively;
- and wherein the VL comprises complementarity determining regions (LCDRs) LCDR1, LCDR2, and LCDR3 comprising amino acid sequences SEQ ID NO:
- 6, SEQ ID NO:
- 7, and SEQ ID NO:
- 8, respectively;
- and
- wherein the VH comprises an amino acid sequence at least 80%, 85%, 90%, 95%, or 100% identical to SEQ ID NO:
- 1 and/or the VL comprises an amino acid sequence at least 80%, 85%, 90%, 95%, or 100% identical to SEQ ID NO:
- 5.
Dependencies are inferred from the claim text.